Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P190023/S033

Navitor Transcatheter Aortic Valve Implantation System

ABBOTT MEDICAL · Decision date Oct 29, 2026

MEDTECHLEDGER EXPLANATIONP190023/S033

What did the FDA approve?

FDA record P190023/S033 is a supplement tied to the Navitor Transcatheter Aortic Valve Implantation System, not a new PMA. The database entry says the decision was APPR and the stated change was a modification of the sterilization process to terminal liquid sterilization (TLS) with glutaraldehyde.

The supplied record also labels this as a Normal 180 Day Track supplement with a reason of Labeling Change - Indications/instructions/shelf life/tradename. It does not provide a new indication, clinical result, or technical specification beyond the sterilization-process change named in the statement.

FDA approval order statement

approval for modification of the sterilization process to terminal liquid sterilization (TLS) with glutaraldehyde.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Oct 29, 2026
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P190023/S033
Regulatory pathway
PMA supplement
Product code
NPT
Decision code
APPR
Decision date
Oct 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Aortic valve, prosthesis, percutaneously delivered.

Product code
NPT
FDA device class
3

For the original device and its historical approval scope, see PMA P190023. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P190023 · Original PMA

    Portico Transcatheter Aortic Valve Implantation System

  2. P190023/S033 received

    Application receipt date recorded by FDA.

  3. P190023/S033 · FDA decision

    Normal 180 Day Track

Timeline entries are records held by MedtechLedger for P190023. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P190023

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA approvalSep 17, 2021FDA

Explore the linked device profile

Other records with product code NPT

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
177 County Rd. B E., St. Paul, MN, 55117

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records